The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey

Basit Öğe Kaydı
dc.contributor.authorKılıçkap, Saadettin
dc.contributor.authorÖlmez, Ömer Fatih
dc.contributor.authorCicin, İrfan
dc.contributor.authorDemirci, Umut
dc.contributor.authorAlan, O.
dc.contributor.authorÇabuk, Devrim
dc.contributor.authorSakalar, Teoman
dc.contributor.authorTatlı, Ali Murat
dc.contributor.authorBuğdaycı, F. Başol
dc.contributor.authorEralp, Yeşim
dc.contributor.authorUysal, Mükremin
dc.contributor.authorDemirkazik, Ahmet
dc.contributor.authorBilgin, Burak
dc.contributor.authorYıldız, Birol
dc.contributor.authorKaraağaç, Mustafa
dc.contributor.authorOkutur, Kerem
dc.contributor.authorSakin, Ayşegül
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:50:05Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:50:05Z
dc.date.issued2018
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description43rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY
dc.descriptionWOS: 000459277303171
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Society for Medical Oncology, Japanese Society of Medical Oncologyen_US
dc.identifier.citationKılıçkap, S., Ölmez, Ö. F., Cicin, İ., Demirci, U., Alan, O., Çabuk, D. ... Sakin, A. (2018). The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey. 43rd ESMO Congress (ESMO) içinde (505-505. ss.). Munich, Germany, October 19-23, 2018.
dc.identifier.endpage505
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.issueSupplement: 8
dc.identifier.startpage505
dc.identifier.urihttps://hdl.handle.net/20.500.12511/1877
dc.identifier.volume29
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartof43rd ESMO Congress (ESMO)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Bildiri Koleksiyonu